This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
128 * | Mon, 8/2/2010, 8:30 AM - 10:20 AM | CC-212 (West) |
Bayesian Analysis of Clinical Trial Data — Contributed Papers | ||
Biopharmaceutical Section , Section on Bayesian Statistical Science , ENAR | ||
Chair(s): Scott William Miller, CDRH/FDA | ||
8:35 AM | A Bayesian Modeling Approach for Safety Data Analysis in Drug Development — Yu Gu, Florida State University ; Ke Zhang, Pfizer Inc. ; Liqiang Yang, Pfizer Inc. | |
8:50 AM | Operational Characteristics of a Go/No-Go Decision Rule in an Early Clinical Trial — Atalanta Ghosh, Johnson & Johnson ; Jose Carlos Pinheiro, Johnson & Johnson ; Paul Rothenberg, Johnson & Johnson | |
9:05 AM | A Conditional Bayesian Logistic Regression Model (BLRM) with Overdose Control — Lu-May Chiang, Novartis Pharmaceuticals Corporation ; Adarsh Joshi, Eli Lilly and Company ; David Ohlssen, Novartis Pharmaceuticals Corporation ; Jyotirmoy Dey, Novartis Pharmaceuticals Corporation | |
9:20 AM | Multivariate Longitudinal Bayesian Imputation for Global Statistical Test, with Applications to Parkinson's Disease — Sheng Luo, The University of Texas School of Public Health ; Andrew Lawson, Medical University of South Carolina ; Jordan J. Elm, Medical University of South Carolina ; Barbara C. Tilley, The University of Texas Health Science Center at Houston | |
9:35 AM | EWOC Online: A Novel Web Application for Computing a Bayesian Phase I Design Method for Dose-Finding with Escalation with Overdose Control — Dror Berel, Cedars-Sinai Medical Center ; Andre Rogatko, Oschin Comprehensive Cancer Institute | |
9:50 AM | A Multistate Modeling and Prediction of Survival Distribution Using Information on Subject's Tumor Response Over Time — Shengyan Hong, MedImmune ; Iiya Lipkovich, Eli Lilly and Company ; Yan Daniel Zhao, Eli Lilly and Company | |
10:05 AM | Floor Discussion |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.